IDiyas

For the Inventor, By the Inventor

Wuppertal, Germany

Arndt Brandes

USPTO Granted Patents = 14

Average Co-Inventor Count = 9.1

ph-index = 8

Forward Citations = 166(Granted Patents)


Company Filing History:

goldMedal13 out of 12,157 
 
Bayer Aktiengesellschaft
 patents
silverMedal1 out of 5 
 
Bayer Aktiengellschaft
 patents

Years Active: 1999-2007

Loading Chart...
14 patents (USPTO):Explore Patents
1. 7192971 - 4-Heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein (2007-03-20),
2. 6958346 - 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein (2005-10-25),
3. 6897317 - 4-Phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein (2005-05-24),
4. 6586613 - Substituted tetrahydronaphthaline and analogous compounds (2003-07-01),
5. 6562976 - 4-phenyltetrahydrochinoline utilized as an inhibitor of the cholesterol ester transfer protein (2003-05-13),
6. 6387929 - 4-heteroaryl-tetrahydroquinolines and their use as inhibitors of the cholesterin-ester transfer protein (2002-05-14),
7. 6291477 - Tetrahydroquinolines, processes for their preparation, pharmaceutical compositions containing them, and their use to prevent or treat hyperlipoproteinaemia (2001-09-18),
8. 6207671 - Cycloalkano-pyridines (2001-03-27),
9. 6127383 - 2-aryl-substituted pyridines (2000-10-03),
10. 6121330 - 5-Hydroxyalkyl substituted phenyls and their use in medicaments for the (2000-09-19),
11. 6069148 - Cycloalkano-pyridines (2000-05-30),
12. 6063788 - Bicyclic-fused pyridines (2000-05-16),
13. 5932587 - Heterocyclic-fused pyridines (1999-08-03),
14. 5925645 - 2-aryl-substituted pyridines (1999-07-20),

Title: Arndt Brandes - Pioneering the Future of Medicine and Technology

Introduction:

Arndt Brandes, a visionary inventor hailing from Wuppertal, Germany, stands tall as a beacon of innovation in the realm of technology and medicine. With a trailblazing spirit and a relentless drive to push the boundaries of what is possible, Brandes has left an indelible mark on the world of innovation.

Latest Patents:

Brandes' latest innovation revolves around 4-Heteroaryl-tetrahydroquinolines and their application as inhibitors of the cholesterin-ester transfer protein. These unique compounds are synthesized through innovative methods involving the condensation of hetero-tetrahydroquinoline aldehydes or the reduction of keto-substituted hetero-tetrahydroquinolines. They hold immense potential as active ingredients in medications targeting atherosclerosis and dyslipidemias.

Career Highlights:

Throughout his illustrious career, Arndt Brandes has amassed an impressive portfolio of 14 patents, showcasing his prowess in innovation and scientific expertise. Having worked with renowned companies like Bayer Aktiengesellschaft, Brandes has contributed significantly to the advancement of pharmaceuticals and healthcare technologies.

Collaborations:

Collaboration plays a crucial role in driving innovation, and Brandes has had the privilege of working alongside esteemed colleagues such as Gunter Schmidt and Hilmar Bischoff. Their collective expertise has fueled groundbreaking research and paved the way for novel advancements in the field of medicine.

Conclusion:

In conclusion, Arndt Brandes exemplifies the epitome of a visionary inventor dedicated to shaping the future of technology and medicine. His groundbreaking patents and collaborative efforts underscore his commitment to driving innovation and leaving a lasting impact on the world. Brandes' legacy will continue to inspire generations of innovators to push the boundaries of what is achievable, ensuring a brighter and more sustainable future for all.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…